1. Home
  2. FNLC vs LAB Comparison

FNLC vs LAB Comparison

Compare FNLC & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Bancorp Inc  (ME)

FNLC

First Bancorp Inc (ME)

HOLD

Current Price

$34.90

Market Cap

395.1M

Sector

Finance

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.90

Market Cap

347.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNLC
LAB
Founded
1864
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
395.1M
347.5M
IPO Year
1995
2008

Fundamental Metrics

Financial Performance
Metric
FNLC
LAB
Price
$34.90
$0.90
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$1.35
AVG Volume (30 Days)
43.0K
6.3M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
5.19%
N/A
EPS Growth
26.34
61.54
EPS
0.80
0.33
Revenue
N/A
$101,937,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.63
P/E Ratio
$43.80
$2.77
Revenue Growth
N/A
N/A
52 Week Low
$24.13
$0.70
52 Week High
$35.93
$1.72

Technical Indicators

Market Signals
Indicator
FNLC
LAB
Relative Strength Index (RSI) 72.27 51.19
Support Level $28.08 $0.90
Resistance Level N/A $1.02
Average True Range (ATR) 1.30 0.07
MACD 0.27 0.01
Stochastic Oscillator 90.58 81.65

Price Performance

Historical Comparison
FNLC
LAB

About FNLC First Bancorp Inc (ME)

First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services, including deposit accounts and consumer, commercial, and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: